# Grace Therapeutics Inc. (GRCE)

Source: https://www.quantisnow.com/company/GRCE
Generated: 2026-11-09T16:23:38.968Z

- Ticker: GRCE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001444192

## Latest GRCE news and filings

- 2026-11-06 02:05 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $33,019 worth of shares (18,442 units at $1.79) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-33019-worth-of-shares-6777632)
- 2026-11-05 13:00 UTC [Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026](https://www.quantisnow.com/insight/grace-therapeutics-announces-participation-in-upcoming-industry-and-investor-events-6774815)
- 2026-10-26 22:06 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $158,601 worth of shares (87,801 units at $1.81) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-158601-worth-of-shares-6758063)
- 2026-10-21 22:06 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $8,001 worth of shares (4,256 units at $1.88) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-8001-worth-of-shares-6753958)
- 2026-10-17 00:42 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $136,178 worth of shares (71,065 units at $1.92) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-136178-worth-of-shares-6749697)
- 2026-10-13 21:45 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $18,765 worth of shares (9,292 units at $2.02) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-18765-worth-of-shares-6745536)
- 2026-10-05 22:46 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $3,490 worth of shares (1,694 units at $2.06) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-3490-worth-of-shares-6737742)
- 2026-10-01 20:30 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $16,404 worth of shares (7,849 units at $2.09) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-16404-worth-of-shares-6732692)
- 2026-10-01 20:05 UTC [Insider Buy] [Amendment: Large owner Opaleye Management Inc. bought $31,687 worth of shares (15,089 units at $2.10) (SEC Form 4)](https://www.quantisnow.com/insight/amendment-large-owner-opaleye-management-inc-bought-31687-worth-of-6732366)
- 2026-09-23 22:19 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $31,687 worth of shares (15,089 units at $2.10) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-31687-worth-of-shares-6724536)
- 2026-09-21 20:20 UTC [SEC Form 4] [SEC Form 4 filed by Director Davis A Brian](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-davis-a-brian-6721762)
- 2026-09-21 20:22 UTC [SEC Form 4] [SEC Form 4 filed by Director Neugeboren Edward](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-neugeboren-edward-6721757)
- 2026-09-21 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Kavuru Vimal](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kavuru-vimal-6721698)
- 2026-09-21 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Director Kottayil George](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kottayil-george-6721685)
- 2026-09-18 20:06 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-6720493)
- 2026-09-10 20:05 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $31,896 worth of shares (15,229 units at $2.09) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-31896-worth-of-shares-6711559)
- 2026-09-10 11:30 UTC [Insider Buy] [Chief Executive Officer Kohli Prashant bought $214,000 worth of shares (100,000 units at $2.14), increasing direct ownership by 468% to 121,357 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-kohli-prashant-bought-214000-worth-of-shares-6710833)
- 2026-09-03 12:00 UTC [Conference Announcement] [Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference](https://www.quantisnow.com/insight/grace-therapeutics-to-participate-in-the-hc-wainright-28th-annual-6704283)
- 2026-09-01 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Chief Medical Officer Macdonald R. Loch](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-medical-officer-macdonald-r-6701345)
- 2026-09-01 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Principal Financial Officer Delaversano Robert J](https://www.quantisnow.com/insight/sec-form-4-filed-by-principal-financial-officer-delaversano-robert-6701332)
- 2026-09-01 20:05 UTC [SEC Form 4] [SEC Form 4 filed by VP Program Management Kumar Amresh](https://www.quantisnow.com/insight/sec-form-4-filed-by-vp-program-management-kumar-amresh-6701330)
- 2026-09-01 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Kohli Prashant](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-kohli-prashant-6701323)
- 2026-09-01 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-grace-therapeutics-inc-6700360)
- 2026-08-24 20:06 UTC [SEC Form S-3] [SEC Form S-3 filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-grace-therapeutics-inc-6692685)
- 2026-08-19 11:44 UTC [Insider Buy] [Large owner Opaleye Management Inc. bought $24,206 worth of shares (11,608 units at $2.09) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-bought-24206-worth-of-shares-6687773)
- 2026-08-13 12:01 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6679436)
- 2026-08-13 12:00 UTC [Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update](https://www.quantisnow.com/insight/grace-therapeutics-announces-first-quarter-2027-financial-results-provides-business-6679374)
- 2026-08-13 11:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-grace-therapeutics-inc-6679303)
- 2026-08-06 20:06 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6668868)
- 2026-08-05 01:00 UTC [Public Offering] [Grace Therapeutics Announces $10 Million Private Placement](https://www.quantisnow.com/insight/grace-therapeutics-announces-10-million-private-placement-6663498)
- 2026-07-28 20:32 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-grace-therapeutics-inc-6651745)
- 2026-07-28 20:29 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-grace-therapeutics-inc-6651701)
- 2026-07-28 11:16 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-other-events-financial-6650600)
- 2026-07-28 11:00 UTC [Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration](https://www.quantisnow.com/insight/grace-therapeutics-announces-receipt-of-type-a-meeting-minutes-from-6650516)
- 2026-06-18 12:15 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-other-events-financial-6608000)
- 2026-06-18 12:01 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6607955)
- 2026-06-18 12:00 UTC [Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update](https://www.quantisnow.com/insight/grace-therapeutics-announces-2026-fiscal-year-end-financial-results-provides-business-6607900)
- 2026-06-18 11:31 UTC [SEC Form 10-K] [SEC Form 10-K filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-grace-therapeutics-inc-6607869)
- 2026-06-05 20:09 UTC [SEC Form 8-K] [Grace Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/grace-therapeutics-inc-filed-sec-form-8-k-leadership-update-financial-6591218)
- 2026-04-27 12:07 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Grace Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-grace-therapeutics-inc-6515629)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GRCE
- Earnings history: https://www.quantisnow.com/earnings/GRCE
- Dividend history: https://www.quantisnow.com/dividends/GRCE
- Insider transactions: https://www.quantisnow.com/insiders/GRCE
- Options chain: https://www.quantisnow.com/options/GRCE
- SEC 8-K filings only: https://www.quantisnow.com/company/GRCE/8-k
- RSS and alerts for GRCE: https://www.quantisnow.com/docs/rss-feeds.md